Examination of Class I HLA-Fc Fusion Proteins in Targeting Cognate Antibody-Producing Cells.
The protocols in this chapter outline the design, production, and evaluation of HLA-Fc proteins, emphasizing their efficacy in vitro and in immunodeficient mouse models, potentially providing new therapeutic approaches for managing HLA-sensitized patients in clinical practice.